News & Videos - BIOTECHNOLOGY

ImmunoPrecise Antibodies Ltd. (IPA) (NASDAQ: IPA) is pleased to announce a strategic partnership with a leading biotechnology company with a multi-billion-dollar market capitalization to advance the discovery and development of Antibody-Drug Conjugates (ADCs) and bispecific antibodies for the treatment of cancer. This collaboration focuses on leveraging contract research expertise while integrating IPA’s proprietary B-cell Select™ platform and artificial intelligence-driven discovery...

Visionary Holdings: Generative AI Leads the Efficiency Revolution, Reshaping the Future of FinTech and Biotechnology PR Newswire TORONTO, Feb. 28, 2025 TORONTO , Feb. 28, 2025 /PRNewswire/ -- In the context of the global economy's digital transformation, Artificial Intelligence (AI) has emerged as a pivotal force driving productivity growth. According to IDC's latest report, AI is expected to contribute up to $19.9 trillion to the global economy by 2030, equivalent to 3.5% of the global GDP....

Fraxion, a leading provider of procure-to-pay solutions, has partnered with ZAGENO, the biotechnology industry's largest AI-powered marketplace for lab supplies. SEATTLE, WASHINGTON / ACCESS Newswire / February 18, 2025 / This powerful integration seamlessly connects Fraxion's efficient, compliant procure-to-pay automation with ZAGENO's expansive marketplace via PunchOut, providing users with a streamlined procurement experience. With access to over 40 million products from more than 5,300...

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Sana Biotechnology, Inc. - SANA PR Newswire NEW YORK, Jan. 8, 2025 NEW YORK , Jan. 8, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Sana Biotechnology, Inc. ("Sana" or the "Company") (NASDAQ: SANA). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980. The investigation concerns whether Sana and certain of its officers...

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Sana Biotechnology, Inc. - SANA PR Newswire NEW YORK, Jan. 2, 2025 NEW YORK , Jan. 2, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Sana Biotechnology, Inc. ("Sana" or the "Company") (NASDAQ: SANA). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980. The investigation concerns whether Sana and certain of its officers...

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Sana Biotechnology, Inc. - SANA PR Newswire NEW YORK, Dec. 27, 2024 NEW YORK , Dec. 27, 2024 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Sana Biotechnology, Inc. ("Sana" or the "Company") (NASDAQ: SANA). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980. The investigation concerns whether Sana and certain of its officers...

Mind Medicine (MindMed) Inc. (Nasdaq: MNMD), (the "Company" or "MindMed"), a clinical-stage biopharmaceutical company developing novel product candidates to treat brain health disorders, today announced that it will be added to the Nasdaq Biotechnology Index (NBI), effective at market open on Monday, December 23, 2024. “2024 has been a transformational year for MindMed. We’ve successfully executed many important milestones, including raising approximately $250 million through two equity...

Spyre Therapeutics Added to the Nasdaq Biotechnology Index PR Newswire WALTHAM, Mass., Dec. 18, 2024 WALTHAM, Mass. , Dec. 18, 2024 /PRNewswire/ -- Spyre Therapeutics, Inc. (NASDAQ: SYRE), a clinical-stage biotechnology company utilizing best-in-class antibody engineering, rational therapeutic combinations, and precision medicine approaches to target improved efficacy and convenience in the treatment of Inflammatory Bowel Disease ("IBD"), today announced Spyre has been added to the Nasdaq...

Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, announced today its common stock will be added to the NASDAQ Biotechnology Index (Nasdaq: NBI), effective prior to market open on Monday, December 23, 2024. The NASDAQ Biotechnology Index is designed to track the performance of a set of securities listed on The NASDAQ Stock Market ® (NASDAQ ® ) that are classified as either biotechnology or...

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Sana Biotechnology, Inc. - SANA PR Newswire NEW YORK, Dec. 3, 2024 NEW YORK , Dec. 3, 2024 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Sana Biotechnology, Inc. ("Sana" or the "Company") (NASDAQ: SANA). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980. The investigation concerns whether Sana and certain of its officers...

PALO ALTO, CA / ACCESSWIRE / November 26, 2024 / Bioz, Inc ., an innovator of AI-powered scientific citation management services, is proud to announce its continued partnership with Gold Biotechnology , a highly respected leader in the field of biological research products. Having collaborated for several years, GoldBio has successfully integrated Bioz's advanced solutions, including Bioz Badges and the Bioz Content Hub, to enhance their visibility and user engagement across the global research...

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Sana Biotechnology, Inc. - SANA PR Newswire NEW YORK, Nov. 25, 2024 NEW YORK , Nov. 25, 2024 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Sana Biotechnology, Inc. ("Sana" or the "Company") (NASDAQ: SANA). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980. The investigation concerns whether Sana and certain of its officers...

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Sana Biotechnology, Inc. - SANA PR Newswire NEW YORK, Nov. 18, 2024 NEW YORK , Nov. 18, 2024 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Sana Biotechnology, Inc. ("Sana" or the "Company") (NASDAQ: SANA). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980. The investigation concerns whether Sana and certain of its officers...

Tsingke Successfully Showcases Innovations at BIO-Europe 2024 PR Newswire BEIJING, Nov. 12, 2024 BEIJING , Nov. 12, 2024 /PRNewswire/ -- Tsingke proudly concluded its participation in BIO-Europe 2024, held from November 4 to 6 in Stockholm, Sweden . As one of the premier global events for the biotechnology, pharmaceutical, and investment sectors, over 5,500 attendees join, representing more than 2,800 companies and over 60 countries. At the event, Tsingke showcased its innovative products and...

In this interview, we speak with Ailsa Craig and Marek Poszepczynski, portfolio managers at International Biotechnology Trust ......

This license covers first-in-class small molecule YKL-40 inhibitors, including the lead molecule OAT-3912, which has shown potential therapeutic benefits in preclinical models in various cancers as well as inflammatory and fibrotic diseases, offering a novel approach to treating these conditions. In addition, the license covers a patent pending for a molecular screening test for further the continuation of the program and the development of new YKL-40 inhibitors. The Bio-dollar value of the...

dBio Partners with Japan's Tamana City to Lead the Future of Smart Healthcare Solutions PR Newswire TAIPEI, Sept. 10, 2024 TAIPEI , Sept. 10, 2024 /PRNewswire/ -- Decentralized Biotechnology Intelligence Co., Ltd (dBio), a global leader in exercise and health platform solutions, has announced a significant milestone in its international expansion. In a strategic move to address Japan's pressing demographic challenges, dBio has signed a Memorandum of Understanding (MOU) with the government of...

CALGARY, AB / ACCESSWIRE / August 22, 2024 / ASIA GREEN BIOTECHNOLOGY CORP. (CSE: ASIA) (" Asia Green " or the " Company ") is pleased to announce that it has entered into a non-binding letter of intent (" LOI ") dated August 22, 2024 to acquire all of the issued and outstanding common shares of Paladin Services Group Ltd. (" Paladin "), a private company that owns a Class II Disposal Well in the Bonnie Glen field area of central Alberta and which has secured disposal commitments from several...

CALGARY, AB / ACCESSWIRE / August 21, 2024 / Asia Green Biotechnology Corp. ("Asia Green" or the "Company") announced today that it has elected to the terminate the previously announced agreement dated February 9, 2024, pursuant to which the Company was to acquire all of the issued and outstanding shares in two private companies being Burton Growers Ltd. and Green-Sight Agri-Holdings Inc. Management of Asia Green has cited delays in obtaining regulatory approval and the ongoing impact of other...

NEW YORK, NY / ACCESSWIRE / August 14, 2024 / Lixte Biotechnology Holdings, Inc. (NASDAQ:LIXT) is a clinical-stage pharmaceutical company focused on new targets for cancer drug development and developing and commercializing cancer therapies. The company will be available for 1-on-1 meetings throughout the day in addition to their presentation. Event: Q3 Investor Summit Date: August 20 th , 2024 Presentation Time: 2:00 pm ET Location: https://www.webcaster4.com/Webcast/Page/3062/51117 The theme...